Taysha Gene Therapies Reports Third Quarter 2024 Financial ...

Tesla, Disney stir market cap stock movers on Thursday

Taysha Gene Therapies Inc (TSHA): Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update; +11.54% ...

Taysha Gene Therapies (TSHA) News Today - MarketBeat

Cantor Fitzgerald reiterated an "overweight" rating and set a $7.00 price target on shares of Taysha Gene Therapies in a research report on Tuesday. November 12 ...

TSHA Taysha Gene Therapies Stock Data, Filings ... - CapEdge

Taysha Gene Therapies Reports Second Quarter 2024 Financial ... Press releases. From Benzinga Pro. Taysha Gene Therapies to Release Third Quarter 2024 Financial ...

Taysha Gene Therapies Reports Second Quarter 2024 Financial ...

scheduled for the third quarter of 2024. We are moving toward reporting cohort-based updates with more mature data sets to provide more fulsome.

Abeona Therapeutics Reports Third Quarter Financial Results

Cash, cash equivalents and short-term investments totaled $67.0 million as of September 30, 2021. Net cash used in operating activities was ...

Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer ...

... reported better-than-expected third-quarter revenue results. Oscar Health, Inc. OSCR. rose 14.6% to $15.44. Taysha Gene Therapies, Inc. TSHA.

Goodwin Represents the Underwriters For Taysha Gene Therapies ...

Goodwin's Capital Markets team advised the underwriters of Taysha Gene Therapies' public offering. Taysha's focus is on advancing AAV-based ...

Taysha Gene Therapies Reports First Quarter 2023 Financial ... - KTLA

Taysha Gene Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update ; ASSETS. Current assets: ; Current assets: Cash ...

Creative Planning Makes New $28,000 Investment in Taysha Gene ...

Creative Planning acquired a new position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the 3rd quarter, ...

Taysha Gene Therapies | LinkedIn

Next week, we will announce our third quarter 2024 earnings and provide a corporate update. ... Today, we reported our second quarter 2024 ...

Artiva Biotherapeutics Revenue 2019-2024 - Stock Analysis

Taysha Gene Therapies ... 2 days ago - Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire ...

Astellas takes a stake in Taysha and gets a chance at next big gene ...

Taysha reported that its cash position as of Sept. 30 was $34.3 million. Chief Financial Officer Kamran Alam said the $50 million from Astellas ...

TSHA - Taysha Gene Therapies Reports Third Quarter 2021 ...

The increase of approximately $7.2 million was primarily attributable to $4.3 million of incremental compensation expense, which included $1.8 million of non- ...

Taysha Gene Therapies Reports Full Year 2023 Financial Results ...

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates · $56.8 million for the full year ...

Intellia Therapeutics Announces Third Quarter 2024 Financial ...

Stock-based compensation expense included in R&D expenses was $24.2 million for the third quarter of 2024. G&A Expenses: General and ...

Taysha Gene Therapies Reports Second Quarter 2024 Financial ...

General and Administrative Expenses: General and administrative expenses were $7.3 million for the three months ended June 30, 2024, compared to ...

Taysha Gene Therapies (NASDAQ:TSHA) Stock Price News

Taysha Gene Therapies (TSHA) 10-K Annual Report - Mar 19th 2024 ... Taysha Gene Therapies fourth quarter and full year 2021 financial results and ...

Hertz Global Holdings Inc (HTZ) Stock Price & News - Google Finance

Hertz Global Holdings Third Quarter 2024 Earnings: Misses Expectations ... Taysha Gene Therapies Inc. $2.37. 7.01%. add_circle_outline. GRAB. Grab Holdings ...

Taysha Gene Therapies to Announce Q2 2024 Financial Results ...

Taysha Gene Therapies, Inc., a biotechnology firm headquartered in Dallas and listed on Nasdaq under the ticker symbol TSHA, has announced ...

Taysha Gene Therapies

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Taysha Gene Therapies to Present Biodistribution Data from ...